Quarry LP’s Fulgent Genetics FLGT Stock Holding History

Quarry LP’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-537	Closed	-$14.1K	–	1713
2025 Q4	$14.1K	Buy	+537	New	+$13.9K	﹤0.01%	1216
2024 Q3	–	Sell	-93	Closed	-$1.82K	–	1779
2024 Q2	$1.82K	Buy	+93	New	+$1.94K	﹤0.01%	1642

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Quarry LP's FLGT Position: Q1 2026 in Review

Quarry LP sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 537 shares — an estimated $14.1K sold.

Quarry LP first reported a position in FLGT in Q2 2024 and held it in 2 quarters. The position peaked at $14.1K in Q4 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

Quarry LP reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
Quarry LP sold 537 Fulgent Genetics shares in Q1 2026, an estimated $14.1K.
Quarry LP first reported a position in Fulgent Genetics in Q2 2024 and held it in 2 quarters.
Quarry LP's Fulgent Genetics position peaked at $14.1K in Q4 2025.
157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.